Mitochondrial Neurogastrointestinal Encephalomyopathy
Description
Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE) syndrome is characterized by the association of gastrointestinal dysmotility, peripheral neuropathy, chronic progressive external ophthalmoplegia and leukoencephalopathy.
Genes related to Mitochondrial Neurogastrointestinal Encephalomyopathy
- RRM2B
- POLG
- TYMP
Clinical Features
Top most frequent phenotypes and symptoms related to Mitochondrial Neurogastrointestinal Encephalomyopathy
- Intellectual disability
- Hearing impairment
- Ataxia
- Sensorineural hearing impairment
- Muscle weakness
- Pain
- Ptosis
- Anemia
- Peripheral neuropathy
- Dysarthria
And another 82 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY have a estimated prevalence of 0.1 per 100k worldwide.— No data available about the known clinical features onset.
Alternative names
Mitochondrial Neurogastrointestinal Encephalomyopathy Is also known as myoneurogastrointestinal encephalopathy syndrome, polip syndrome, mitochondrial neurogastrointestinal encephalopathy syndrome, tymp-related, polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudoobstruction, mngie, mngie, tymp-related.
Researches and researchers
Doctors, researchs, and experts related to Mitochondrial Neurogastrointestinal Encephalomyopathy extracted from public data.
Mitochondrial Neurogastrointestinal Encephalomyopathy Experts map
Current Researchs and researchers
-
Investigator of research project - Coordinator of research networkBARCELONA — Dr Jordi BARQUINERO
-
Institution/s:
— Vall d'Hebron Institut de Recerca VHIR -
Research area/topic::
New strategies to improve efficacy and reduce immunogenicity in gene therapy of hereditary diseases
-
Institution/s:
-
Responsible for diagnostic tests - Investigator of research project - Manager of registryBARCELONA — Dr Ramón MARTÍ SEVES
-
Institution/s:
— Vall d'Hebron Institut de Recerca VHIR -
Research area/topic::
Optimization of adeno-associated vectors using the TYMP gene for MNGIE gene therapy
-
Institution/s:
-
Clinical expert - Principal investigator of clinical trial - Contact person of registry - Coordinator of research networkBIRMINGHAM — Dr Anupam CHAKRAPANI
-
Institution/s:
— Birmingham Children's Hospital NHS Foundation Trust
— Birmingham Children's Hospital NHS Foundation Trust -
Research area/topic::
Midlands Muscle Network
-
Institution/s:
-
Investigator of research project - Contact person of patient organisationLONDON — Dr Bridget E BAX
-
Institution/s:
— Clinical Developmental Sciences, The Aplastic Anaemia Trust
— St George's University of London -
Research area/topic::
MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathy
-
Institution/s:
-
Investigator of research project - Contact person of patient organisationST NEOTS — Dr Bridget E BAX
-
Institution/s:
— Clinical Developmental Sciences, The Aplastic Anaemia Trust
— St George's University of London -
Research area/topic::
MICA: Clinical development of erythrocyte encapsulated thymidine phosphorylase - a therapy for mitochondrial neurogastrointestinal encephalomyopathy
-
Institution/s:
Mitochondrial Neurogastrointestinal Encephalomyopathy Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RRM2B
Specificity
100 %
Genes
34 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RRM2B
Specificity
100 %
Genes
34 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RRM2B
Specificity
100 %
Genes
34 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RRM2B
Specificity
100 %
Genes
34 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
SLC25A4, SUCLA2, SUCLG1, SUCLG2, TWNK, TK2, MGME1, RRM2B, DGUOK, TYMP, MPV17, OPA1, OPA3, POLG, POLG2
Specificity
20 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
SLC25A4, TWNK, MGME1, RRM2B, OPA1, OPA3, POLG, POLG2
Specificity
25 %
Genes
67 % |
![]() By Athena Diagnostics Inc (United States).
RRM2B, TYMP, MT-TL1
Specificity
67 %
Genes
67 % |
You can get up to 248 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A